57
Participants
Start Date
March 29, 2021
Primary Completion Date
October 31, 2022
Study Completion Date
October 31, 2022
Choice Architecture
"1. Providers will receive general training on TPT benefits, indications, and contra-indications.~2. Providers will be provided with updated ART and TPT prescribing approach. This will be adapted to the country context and may include a pre-printed prescription pad (Mozambique), adaptations in clinical stationary (Zimbabwe), or adaptations to an electronic prescribing system (Malawi).~3. The pharmacy or clinician (if the clinician dispenses) will dispense ART, cotrimoxazole, and TPT as prescribed"
KNCV Tuberculosis Foundation, Lilongwe
Aurum Institute, Maputo
Clinton Health Access Initiative, Harare
Collaborators (1)
KNCV Tuberculosis Foundation
OTHER
Clinton Health Access Initiative, Zimbabwe
OTHER
Aurum Institute
OTHER
Johns Hopkins University
OTHER